FFMMX
Price
$60.01
Change
+$0.23 (+0.38%)
Updated
Dec 24 closing price
Net Assets
111.8B
HDGCX
Price
$32.92
Change
+$0.11 (+0.34%)
Updated
Dec 24 closing price
Net Assets
18.49B
Interact to see
Advertisement

FFMMX vs HDGCX

Header iconFFMMX vs HDGCX Comparison
Open Charts FFMMX vs HDGCXBanner chart's image
American Funds American Mutual 529-F-2
Price$60.01
Change+$0.23 (+0.38%)
VolumeN/A
Net Assets111.8B
Hartford Dividend and Growth C
Price$32.92
Change+$0.11 (+0.34%)
VolumeN/A
Net Assets18.49B
FFMMX vs HDGCX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFMMX has more cash in the bank: 112B vs. HDGCX (18.5B). FFMMX pays higher dividends than HDGCX: FFMMX (1.65) vs HDGCX (0.67). FFMMX was incepted earlier than HDGCX: FFMMX (5 years) vs HDGCX (27 years). HDGCX (1.73) is less costly to investors than FFMMX (0.36). FFMMX is a more actively managed with annual turnover of: 31.00 vs. HDGCX (28.00). FFMMX has a lower initial minimum investment than HDGCX: FFMMX (250) vs HDGCX (2000). FFMMX annual gain was more profitable for investors over the last year : 8.57 vs. HDGCX (3.16). FFMMX return over 5 years is better than : 50.25 vs. HDGCX (29.08).
FFMMXHDGCXFFMMX / HDGCX
Total Expense Ratio0.361.7321%
Annual Report Gross Expense Ratio0.361.7321%
Fund Existence5 years27 years-
Gain YTD10.1854.618221%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets112B18.5B605%
Annual Yield % from dividends1.650.67247%
Returns for 1 year8.573.16271%
Returns for 3 years30.9919.79157%
Returns for 5 years50.2529.08173%
Returns for 10 yearsN/A56.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XDSQ42.150.13
+0.30%
Innovator US Eq Acltd ETF™ Quarterly
HEQT32.200.07
+0.22%
Simplify Hedged Equity ETF
TIPX19.080.03
+0.16%
State Street® SPDR® Blmbg 1-10 YrTIPSETF
BESF33.65-0.12
-0.36%
Bastion Energy ETF
BIS9.01-0.24
-2.60%
ProShares UltraShort Nasdaq Biotech